**Core Concept**
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of viral infections caused by the human immunodeficiency virus (HIV) and hepatitis B virus (HBV). It works by inhibiting the reverse transcriptase enzyme, which is essential for the replication of retroviruses and hepadnaviruses.

**Why the Correct Answer is Right**
Lamivudine specifically targets the HBV DNA polymerase, an enzyme responsible for the replication of the HBV genome. By incorporating itself into the viral DNA chain, lamivudine acts as a chain terminator, preventing the completion of the viral DNA strand and thereby inhibiting viral replication. This mechanism of action is unique to lamivudine and is responsible for its antiviral effects against HBV.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not correct because lamivudine does not act against the human T-lymphotropic virus (HTLV), which is a different type of retrovirus.
**Option B:** This option is incorrect because lamivudine does not target the human herpesvirus (HHV), which includes viruses such as herpes simplex virus and varicella-zoster virus.
**Option C:** This option is not correct because lamivudine does not act against the hepatitis C virus (HCV), which is a different type of RNA virus.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that lamivudine is a dual-nucleoside reverse transcriptase inhibitor, meaning it can be used in combination with other antiretroviral agents to treat HIV infection, in addition to its use in the treatment of HBV.

**Correct Answer:** C. Hepatitis B virus (HBV)